Skip to main content

Bayer Healthcare Expands License for Genedata's Software

NEW YORK (GenomeWeb News) – Bayer Healthcare has expanded a ten-year license agreement for Genedata’s software to include all of Bayer Schering Pharma’s drug research sites, Genedata said today.
 
The global agreement builds on a relationship dating back to 1999 and expands a renewed agreement from 2006 that gave Bayer Schering access to Genedata’s Phylosopher and Expressionist software at sites in the US and in Germany.
 
Genedata said it also will support integration services and will provide interfaces to existing research logistics infrastructure such as lab technologies and related IT systems.
 
Phylosopher is used to manage biological target information and Expressionist is used in quality control of gene expression data, for statistical analysis, and for processing data from high-throughput studies.
 
Financial terms of the agreement were not released.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.